Search for:
Category

Product Regulation & Liability

Category
In Product Regulation & Liability

European Union tightens rules on e-commerce and non-EU product safety

by , , , and 1 Min Read

On 9 July 2025, the European Parliament (EP) adopted a resolution pressing for sweeping reforms in the e-commerce and imports sector, with a focus on consumer protection, product regulation, and unfair competition.1 The resolution sets out a series of measures, including calling for the swift implementation of the Digital Product Passport (DPP), strengthened customs enforcement through reform of the Union Customs Code (UCC), and the removal of the EUR 150 customs duty exemption for low-value consignments. The resolution will now be put submitted to the European Council and the European Commission for consideration.

Read More
In Product Regulation & Liability

European Union: EU restricts access of Chinese medical devices to the European market

by , and 7 Mins Read

For the first time, the European Commission completed an investigation under the International Procurement Instrument (IPI) and implemented measures to limit the participation of economic operators from non-EU countries – in this particular case, China – in the EU public procurement market. After EU suppliers of medical devices have arguably been denied fair access to Chinese government contract opportunities for years, the EU has now responded with Implementing Regulation (EU) 2025/1197 that requires contracting authorities/entities in all EU member states to exclude Chinese suppliers – and to a certain extent products manufactured in China – from larger public procurement contracts for medical devices.

In Corporate Compliance

Singapore: Clarification on non-preferential country of origin declarations

by , and 4 Mins Read

In response to heightened scrutiny over country of origin declarations amid ongoing global tariff tensions, Singapore Customs issued Circular No. 06/2025 on 9 June 2025 to provide important clarification on the applicable preferential and non-preferential rules of origin when declaring the “country of origin” for importation into, exportation out of, and transshipments through Singapore.

In Product Regulation & Liability

Webinar Summary – Product regulation and safety: a new era for the UK and EU – Wednesday 11 June 2025

by , , , and 1 Min Read

Product regulation and safety is a key area of focus for consumer protection authorities around the world. In this session, our speakers discussed recent developments in the regulation of product safety which businesses supplying products in the UK and EU need to be aware of. The panel considered the compliance…

Read More
In Product Regulation & Liability

International: FDA to enhance unannounced inspections of foreign manufacturing facilities in countries including China

by , and 4 Mins Read

On 6 May 2025, the US Food and Drug Administration (FDA) announced that it will expand the use of unannounced inspections at foreign manufacturing facilities that produce foods, essential medicines, and other medical products intended for US consumers and patients. The announcement came one day after the White House issued an Executive Order instructing FDA to provide regulatory relief to promote domestic production of critical medicines and improve FDA’s risk-based inspection regime to enhance routine inspections of foreign facilities.

In International

International: FDA to enhance unannounced inspections of foreign manufacturing facilities in countries including China

by , and 4 Mins Read

On 6 May 2025, the US Food and Drug Administration (FDA) announced that it will expand the use of unannounced inspections at foreign manufacturing facilities that produce foods, essential medicines, and other medical products intended for US consumers and patients. The announcement came one day after the White House issued an Executive Order instructing FDA to provide regulatory relief to promote domestic production of critical medicines and improve FDA’s risk-based inspection regime to enhance routine inspections of foreign facilities. The expansion will build upon FDA’s existing Foreign Unannounced Inspection Pilot Program in India and China, with the aim of ensuring that foreign facilities will receive the same level of regulatory oversight and scrutiny as domestic facilities.

In Product Regulation & Liability

United States: Electronic shelf labels pose myriad risks for retailers

by , and 3 Mins Read

Retailers are increasingly adopting electronic shelf labels (ESLs) to streamline pricing updates and enhance operational efficiency. ESLs offer quick price adjustments, improved accuracy, and reduced labor. However, concerns about price gouging, demographic-based pricing, and technical glitches have emerged. Lawmakers and regulators are scrutinizing the technology, emphasizing the need for businesses to consider legal risks before deployment.

Read More
In Cybersecurity, Data and Tech

Singapore: Health Sciences Authority launches public consultation on the Best Practices Guide for Medical Device Cybersecurity

by and 3 Mins Read

On 10 March 2025, the Health Sciences Authority launched its public consultation for the draft on the Best Practices Guide for Medical Device Cybersecurity. The document provides medical device manufacturers and healthcare providers with best practice recommendations and considerations on general cybersecurity principles to protect the security of medical devices for their entire product life cycle.

In Product Regulation & Liability

Singapore: Ministry of Health announces reforms to the industry with updates to the regime under the Healthcare Services Act

by and 3 Mins Read

On 7 March 2025, the Ministry of Health announced a host of changes to the healthcare system to address the shifting needs of the Singapore population. These changes included a review of advertising regulations for certain healthcare professionals, the recognition of family medicine as a medical specialty and the introduction of registration requirements for psychologists.

Read More
Load More